A dozen lawyers will lead a growing number of lawsuits brought over Tepezza, an infusion drug that treats thyroid eye disease.

More than 40 lawsuits allege that Tepezza, which the U.S. Food and Drug Administration approved in 2020, causes permanent hearing loss or ringing in the ears and that manufacturer Horizon Therapeutics USA Inc. failed to warn patients of these problems.